Serum Glycogen Synthase 3 Beta Levels: A Promissory Marker for Patients with Heart Failure.
作者信息
Alesso Claudia Aznar, Queda João, Mohty Dania, Salemi Vera Maria Cury
机构信息
Centro Universitário Fieo - UNIFIEO, São Paulo, SP - Brasil.
Faculdade de Medicina de Santo Amaro, São Paulo, SP - Brasil.
出版信息
Arq Bras Cardiol. 2024 Dec 9;121(11):e20240684. doi: 10.36660/abc.20240684. eCollection 2024.
Abstract
摘要
相似文献
1
Serum Glycogen Synthase 3 Beta Levels: A Promissory Marker for Patients with Heart Failure.血清糖原合酶3β水平：心力衰竭患者的一个有前景的标志物。
Arq Bras Cardiol. 2024 Dec 9;121(11):e20240684. doi: 10.36660/abc.20240684. eCollection 2024.
2
Determination of Serum Glycogen Synthase 3 Beta Levels in Patients with Heart Failure, a Novel Marker for Diagnosis and Defining Disease Severity?心力衰竭患者血清糖原合酶 3β 水平的测定：一种新的诊断标志物及其对疾病严重程度的定义？
Arq Bras Cardiol. 2024 Nov 22;121(11):e20240155. doi: 10.36660/abc.20240155. eCollection 2024.
3
In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3.锂抑制糖原合酶激酶-3在大脑中的体内证据。
Neuropsychopharmacology. 2004 Jan;29(1):32-8. doi: 10.1038/sj.npp.1300283.
4
[The role of glycogen synthase kinase-3 beta in the pathogenesis of liver ischemia reperfusion injury].糖原合成酶激酶-3β在肝脏缺血再灌注损伤发病机制中的作用
Zhonghua Gan Zang Bing Za Zhi. 2011 Jul;19(7):547-51. doi: 10.3760/cma.j.issn.1007-3418.2011.07.018.
5
Insulin reduces the multiple organ injury and dysfunction caused by coadministration of lipopolysaccharide and peptidoglycan independently of blood glucose: role of glycogen synthase kinase-3beta inhibition.胰岛素可减轻脂多糖和肽聚糖联合给药所致的多器官损伤和功能障碍，且独立于血糖：糖原合酶激酶-3β抑制的作用
Crit Care Med. 2006 May;34(5):1489-96. doi: 10.1097/01.CCM.0000215457.83953.E3.
6
Effect of inhibition of glycogen synthase kinase-3 on cardiac hypertrophy during acute pressure overload.急性压力超负荷期间糖原合酶激酶-3抑制对心肌肥大的影响。
Gen Thorac Cardiovasc Surg. 2010 Jun;58(6):265-70. doi: 10.1007/s11748-009-0505-2. Epub 2010 Jun 13.
7
Regulation of Akt mRNA and protein levels by glycogen synthase kinase-3beta in adrenal chromaffin cells: effects of LiCl and SB216763.糖原合酶激酶-3β对肾上腺嗜铬细胞中Akt mRNA和蛋白水平的调控：氯化锂和SB216763的作用
Eur J Pharmacol. 2008 May 31;586(1-3):82-9. doi: 10.1016/j.ejphar.2008.02.075. Epub 2008 Mar 4.
8
Loss of mitochondrial pyruvate transport initiates cardiac glycogen accumulation and heart failure.线粒体丙酮酸转运功能丧失引发心脏糖原积累和心力衰竭。
bioRxiv. 2024 Jun 9:2024.06.06.597841. doi: 10.1101/2024.06.06.597841.
9
Cyclic AMP-dependent and cyclic AMP-independent antagonism of insulin activation of cardiac glycogen synthase.环磷酸腺苷（cAMP）依赖性和非环磷酸腺苷依赖性对心脏糖原合酶胰岛素激活的拮抗作用。
J Biol Chem. 1982 Feb 10;257(3):1448-57.
10
Allosteric regulation of glycogen synthase and hexokinase by glucosamine-6-phosphate during glucosamine-induced insulin resistance in skeletal muscle and heart.在氨基葡萄糖诱导的骨骼肌和心脏胰岛素抵抗过程中，6-磷酸氨基葡萄糖对糖原合酶和己糖激酶的变构调节
Diabetes. 1999 May;48(5):1101-7. doi: 10.2337/diabetes.48.5.1101.
本文引用的文献
1
Determination of Serum Glycogen Synthase 3 Beta Levels in Patients with Heart Failure, a Novel Marker for Diagnosis and Defining Disease Severity?心力衰竭患者血清糖原合酶 3β 水平的测定：一种新的诊断标志物及其对疾病严重程度的定义？
Arq Bras Cardiol. 2024 Nov 22;121(11):e20240155. doi: 10.36660/abc.20240155. eCollection 2024.
2
Glycogen synthase kinase-3β: A multifaceted player in ischemia-reperfusion injury and its therapeutic prospects.糖原合酶激酶-3β：在缺血再灌注损伤中的多面手及其治疗前景。
J Cell Physiol. 2024 Sep;239(9):e31335. doi: 10.1002/jcp.31335. Epub 2024 Jul 4.
3
2024 update in heart failure.2024年心力衰竭治疗进展
ESC Heart Fail. 2025 Feb;12(1):8-42. doi: 10.1002/ehf2.14857. Epub 2024 May 28.
4
Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets.肥胖与射血分数保留的心力衰竭：新的认识和病理生理靶点。
Cardiovasc Res. 2023 Feb 3;118(18):3434-3450. doi: 10.1093/cvr/cvac120.
5
Uncoupling between intravascular and distending pressures leads to underestimation of circulatory congestion in obesity.血管内压和扩张压之间的解耦导致肥胖患者循环充血的低估。
Eur J Heart Fail. 2022 Feb;24(2):353-361. doi: 10.1002/ejhf.2377. Epub 2021 Nov 21.
6
Biomarkers for the diagnosis and management of heart failure.心力衰竭的诊断和管理生物标志物。
Heart Fail Rev. 2022 Mar;27(2):625-643. doi: 10.1007/s10741-021-10105-w. Epub 2021 Apr 14.
7
Role of GSK-3 in Cardiac Health: Focusing on Cardiac Remodeling and Heart Failure.GSK-3 在心脏健康中的作用：聚焦于心脏重构和心力衰竭。
Curr Drug Targets. 2021;22(13):1568-1576. doi: 10.2174/1389450122666210224105430.
8
Diagnostic accuracy of natriuretic peptides for acute heart failure: a review.利钠肽对急性心力衰竭的诊断准确性：综述。
Eur Rev Med Pharmacol Sci. 2018 Apr;22(8):2415-2420. doi: 10.26355/eurrev_201804_14834.
9
Inhibition of glycogen synthase kinase-3β attenuates organ injury and dysfunction associated with liver ischemia-reperfusion and thermal injury in the rat.糖原合酶激酶-3β的抑制作用可减轻大鼠肝脏缺血再灌注和热损伤相关的器官损伤及功能障碍。
Shock. 2015 Apr;43(4):369-78. doi: 10.1097/SHK.0000000000000298.
10
Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis.心脏中的糖原合酶激酶3（GSK3）：肥厚信号传导的整合点及治疗靶点？一项批判性分析。
Br J Pharmacol. 2008 Mar;153 Suppl 1(Suppl 1):S137-53. doi: 10.1038/sj.bjp.0707659. Epub 2008 Jan 21.
Zotero 插件